Lexaria Bioscience Corp. (LEXXW) News
Track canonical SquawkNews coverage tagged to LEXXW, Lexaria Bioscience Corp.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 10 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
LEXX LEXXW - Lexaria Updates Financial Position
LEXX LEXXW - Lexaria Updates Financial Position
NEWS | Sep 17, 2026, 01:10 PM UTC
M
Lexaria closes warrant exercises raising about $5.9 million gross
EQUITY | Sep 09, 2026, 08:15 PM UTC
L
Lexaria exercise of warrants raises about $5.9M gross proceeds
Lexaria announced the exercise of warrants for approximately $5.9 million in gross proceeds.
EQUITY | Sep 08, 2026, 12:00 PM UTC
L
LEXX LEXXW - Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
LEXX LEXXW - Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 04, 2026, 01:20 PM UTC
L
Lexaria receives a USD tax rebate payment
Lexaria receives a USD tax rebate payment, per the latest update.
EQUITY | Sep 01, 2026, 01:15 PM UTC
L
Lexaria enters material transfer agreement with PegBio
Lexaria said it enters a material transfer agreement with PegBio; no catalyst, terms, or financial impact were supplied in the alert.
MNA | Aug 13, 2026, 01:00 PM UTC
H
Lexaria Sets Reverse Stock Split Date
Lexaria announces reverse stock split effective date
EQUITY | Jul 30, 2026, 03:00 PM UTC
L
Lexaria Updates Business Development
(TheNewswire)
EQUITY | Jul 06, 2026, 01:10 PM UTC
M
LEXX: Begins Dosing
Lexaria's human study GLP-1-H26-7 has begun dosing on schedule
EQUITY | Jun 25, 2026, 01:10 PM UTC
L
LEXX: Animal Study Begins
Lexaria's animal study GLP-1-A26-1 has begun dosing on schedule
EQUITY | Jun 23, 2026, 01:26 PM UTC